Yaara Porat

Haifa, HA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells.

Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells.

Journal: Frontiers in oncology

Published: February 12, 2025

The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields).

The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields).

Journal: Cell death discovery

Published: September 25, 2024

Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo system.

Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo system.

Journal: STAR protocols

Published: August 14, 2024

Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical study.

Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical study.

Journal: Frontiers in microbiology

Published: September 19, 2023

Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas.

Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas.

Journal: International journal of molecular sciences

Published: December 15, 2022

Protocol for live-cell imaging during Tumor Treating Fields treatment with Inovitro Live.

Protocol for live-cell imaging during Tumor Treating Fields treatment with Inovitro Live.

Journal: STAR protocols

Published: April 04, 2022

Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models.

Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 27, 2021

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.

Journal: Cancer immunology, immunotherapy : CII

Published: September 03, 2019

AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields).

AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields).

Journal: Cell death & disease

Published: May 14, 2018

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields).

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields).

Journal: Journal of visualized experiments : JoVE

Published: May 19, 2017

Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells.

Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells.

Journal: Radiation oncology (London, England)

Published: March 13, 2017

Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo.

Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo.

Journal: International journal of cancer

Published: February 18, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026